These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3128727)
21. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes. Quist E; Satumtira N; Vasan R Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428 [TBL] [Abstract][Full Text] [Related]
22. A novel site of action of a high affinity A1 adenosine receptor antagonist. Ramkumar V; Stiles GL Biochem Biophys Res Commun; 1988 Jun; 153(3):939-44. PubMed ID: 3134023 [TBL] [Abstract][Full Text] [Related]
23. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544 [TBL] [Abstract][Full Text] [Related]
24. Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes. Gawler D; Milligan G; Spiegel AM; Unson CG; Houslay MD Nature; 1987 May 21-27; 327(6119):229-32. PubMed ID: 3106832 [TBL] [Abstract][Full Text] [Related]
25. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. Murayama T; Itahashi Y; Nomura Y J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396 [TBL] [Abstract][Full Text] [Related]
26. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. Kather H; Bieger W; Michel G; Aktories K; Jakobs KH J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284 [TBL] [Abstract][Full Text] [Related]
27. Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Böhm M; Gierschik P; Jakobs KH; Pieske B; Schnabel P; Ungerer M; Erdmann E Circulation; 1990 Oct; 82(4):1249-65. PubMed ID: 2169357 [TBL] [Abstract][Full Text] [Related]
28. Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni. Parsons WJ; Stiles GL J Biol Chem; 1987 Jan; 262(2):841-7. PubMed ID: 3805010 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding. Liang BT J Pharmacol Exp Ther; 1989 Jun; 249(3):775-84. PubMed ID: 2732946 [TBL] [Abstract][Full Text] [Related]
30. The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP. Wesslau C; Smith U Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):41-6. PubMed ID: 1280115 [TBL] [Abstract][Full Text] [Related]
32. A permissive role of pertussis toxin substrate G-protein in P2-purinergic stimulation of phosphoinositide turnover and arachidonate release in FRTL-5 thyroid cells. Cooperative mechanism of signal transduction systems. Okajima F; Sato K; Nazarea M; Sho K; Kondo Y J Biol Chem; 1989 Aug; 264(22):13029-37. PubMed ID: 2546944 [TBL] [Abstract][Full Text] [Related]
33. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies. Zgombick JM; Beck SG; Mahle CD; Craddock-Royal B; Maayani S Mol Pharmacol; 1989 Apr; 35(4):484-94. PubMed ID: 2495434 [TBL] [Abstract][Full Text] [Related]
34. Diabetes abolishes the GTP-dependent, but not the receptor-dependent inhibitory function of the inhibitory guanine-nucleotide-binding regulatory protein (Gi) on adipocyte adenylate cyclase activity. Strassheim D; Milligan G; Houslay MD Biochem J; 1990 Mar; 266(2):521-6. PubMed ID: 2156498 [TBL] [Abstract][Full Text] [Related]
35. Glucagon desensitization of adenylate cyclase and stimulation of inositol phospholipid metabolism does not involve the inhibitory guanine nucleotide regulatory protein Gi, which is inactivated upon challenge of hepatocytes with glucagon. Murphy GJ; Gawler DJ; Milligan G; Wakelam MJ; Pyne NJ; Houslay MD Biochem J; 1989 Apr; 259(1):191-7. PubMed ID: 2497730 [TBL] [Abstract][Full Text] [Related]
36. Cross-talk between glucagon- and adenosine-mediated signalling systems in rat hepatocytes: effects on cyclic AMP-phosphodiesterase activity. Robles-Flores M; Allende G; Piña E; García-Sáinz JA Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):763-7. PubMed ID: 8554517 [TBL] [Abstract][Full Text] [Related]
37. Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium. Ungerer M; Böhm M; Schwinger RH; Erdmann E Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):577-85. PubMed ID: 2392160 [TBL] [Abstract][Full Text] [Related]
38. Increased sensitivity of fat cell adenylate cyclase to stimulatory agonists during fasting is not related to impaired inhibitory coupling system. Lacasa D; Agli B; Giudicelli Y FEBS Lett; 1986 Jul; 202(2):260-6. PubMed ID: 3013688 [TBL] [Abstract][Full Text] [Related]
39. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs. Harrison SA; Chang ML; Beavo JA Circulation; 1986 Mar; 73(3 Pt 2):III109-16. PubMed ID: 3002661 [TBL] [Abstract][Full Text] [Related]
40. Cross talk between stimulatory and inhibitory guanosine 5'-triphosphate binding proteins: role in activation and desensitization of the adenylate cyclase response to vasopressin. Skorecki KL; Verkman AS; Ausiello DA Biochemistry; 1987 Jan; 26(2):639-45. PubMed ID: 3103683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]